Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2026. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 6157829014 | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 6157830016 | ALK (anaplastic lymphoma kinase) inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 6157831017 | Substance with anaplastic lymphoma kinase inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Has disposition (attribute) | Anaplastic lymphoma kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ensartinib (substance) | Is a | True | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Ceritinib | Is a | True | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Crizotinib (substance) | Is a | True | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Alectinib (substance) | Is a | True | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Brigatinib (substance) | Is a | True | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Inferred relationship | Some | |
| Lorlatinib | Is a | True | Substance with anaplastic lymphoma kinase inhibitor mechanism of action (substance) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR